9.78 +0.03 (0.31%)
After hours: 7:22PM EDT
|Bid||9.73 x 29200|
|Ask||9.80 x 34100|
|Day's Range||9.73 - 10.13|
|52 Week Range||9.73 - 19.59|
|Beta (3Y Monthly)||1.59|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.68 (6.30%)|
|1y Target Est||N/A|
Brooklinen Founder Rich Fulop sits down with Yahoo Finance's Julie Hyman, Adam Shapiro, and Pras Subramanian to discuss his company's direct-to-consumer approach to selling bedding accessories and loungewear.
Looper Capital Markets Managing Director Anthony Chukumba discusses what's next for Bed Bath & Beyond after their disappointing earnings with Yahoo Finance's Julie Hyman and Adam Shapiro.
The flurry of new highs notched by the S&P 500 is perhaps the clearest evidence of the decade-long golden age stocks we've been living in. Since the disastrous days of '08 and bottom carved in the Spring of '09, equities have grown 343%. But not all companies have been boosted during the buying binge. Some sad saps remain stocks to sell.Today we'll highlight three such losers.These stocks to sell weren't hard to find. Indeed, in a day of high flying equities tagging record-setting prices, all you have to do is look for the few stocks that are hitting new lows. There's a stink about them. Maybe they have deteriorating fundamentals. Or perhaps they find themselves in an out-of-favor sector. In any case, they're worth steering clear. Or you could deploy bearish trades to profit from their pain.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Stocks Top Investors Are Buying Now Let's take a closer look at three deathly looking stocks to sell. Baidu (BIDU) Click to Enlarge Source: ThinkorSwim Since peaking last year at $284.22, Baidu (NASDAQ:BIDU) shares are down over 53%. The unwinding accelerated after May's dismal earnings report sent the shares plunging around 20% amid massive volume. Since then, BIDU stock has proven altogether unable to lift itself from the mat.And with the specter of another certain earnings announcement looming later this month, I think the selling could begin anew as shareholders who were holding out for a recovery finally jump ship.To bank on pre-earnings jitters, we could buy put options. The Aug $110 puts can be purchased for around $3.80 and offer a lower cost and limited risk way to speculate on additional weakness. 3 Stocks to Sell: Bed Bath & Beyond (BBBY) Click to Enlarge Source: ThinkorSwim Remember the powerful recovery Bed Bath & Beyond (NASDAQ:BBBY) staged over the first four months of the year? We're talking about the robust 87% ramp that pulled-in bargain hunters and spectators willing to bet on a turnaround.Well, it's gone. All of it.And this week, BBBY stock officially broke below the December low that marked the beginning of its once-promising ascent. That means every single person who got suckered into banking on the resurrection is now cursed with a losing position. And they're all likely sellers at higher prices, which is otherwise known as overhead supply.Couple the flawed fundamentals with terrible technicals and you have a toxic brew pointing toward lower prices.Unfortunately, with BBBY already down sharply after last week's earnings release, it's tough to recommend new bear trades here. But I would be a seller into any strength. * 3 Food Stocks to Buy for Fast and Big Profits The depths beckon. 3 Stocks to Sell: Halliburton (HAL) Click to Enlarge Source: ThinkorSwim Oil stocks have been poison to portfolios in recent years. And perhaps none best illustrates the damage inflicted than Halliburton (NYSE:HAL). Just last year the oil service titan was flirting with $60. Now it's threatening to break into the teens.The downtrend has taken a few pit stops along the way, but overall the descent has been relentless. Its latest two-month pause just gave way to renewed selling, and this morning HAL stock is working on its fifth straight down day. The next earnings report is right around the corner on July 22nd and could provide some relief, but I doubt it.If you're willing to bet with bears into the event, then buy the Sep $22.50/$20 bear put for around $1.15.As of this writing, Tyler Craig didn't hold a position in any of the aforementioned securities. Check out his recently released Bear Market Survival Guide to learn how to defend your portfolio against market volatility. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks Top Investors Are Buying Now * The 10 Best Cryptocurrencies to Keep on Your Radar * 7 Marijuana Penny Stocks That Could Triple (But You Won't Make Money) The post 3 Stocks That Look Like Death appeared first on InvestorPlace.
Investors are always looking for growth in small-cap stocks like Bed Bath & Beyond Inc. (NASDAQ:BBBY), with a market...
In early morning trading, futures on the Dow Jones Industrial Average are up 0.29%, and S&P 500 futures are higher by 0.22%. Nasdaq-100 futures have added 0.20%.Source: Shutterstock In the options pits, calls continued their usual leadership role on Thursday, while overall volume settled to average levels. Specifically, about 18 million calls and 14.4 million puts changed hands on the session.Meanwhile, over at the CBOE, the single-session equity put/call volume ratio normalized after Wednesday's super low reading. The metric climbed back to 0.61 to end in the location of the 10-day moving average.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOptions traders swarmed the following three stocks. Bed Bath & Beyond (NYSE:BBBY) continued its trend of earnings deterioration with weak numbers for the fiscal first-quarter. Merck (NYSE:MRK) and CVS Health (NYSE:CVS) both saw sharp moves following news that the White House was ending its drug rebate plans.Let's take a closer look: Bed Bath & Beyond (BBBY)A quick Google search following this week's earnings release for ailing retailer, Bed Bath & Beyond, reveals a litany of ominous-sounding headlines. And, well, they're all probably justified. For the fiscal first-quarter, the company posted a loss of $2.91 per share. After adjusting for miscellaneous items, however, earnings came in at 12 cents per share, marking a 68% decline. Comps were down 6.6%, and revenue grew to $2.57, which was well below last year's $2.75 billion in the same quarter.Sellers took to the streak driving BBBY stock as low as $10.43 before a rapid recovery carried it back near the high of the day. The chart continues to look like garbage, warning anyone who cares about technical analysis to stay far away. That said, the intraday rebound was impressive and could deliver some short-term relief. * 7 Short Squeeze Stocks With Big Upside Potential On the options trading front, puts were all the rage. Total activity ballooned to 777% of the average daily volume, with 108,356 contracts traded; 70% of the trading came from call options alone.The expected move ahead of earnings was $1.54 or 13.3%, so with the stock rallying back to near unchanged on the session, anyone who shorted volatility before the report and held steady through the morning drop came out a big winner. CVS Health (CVS)CVS Health has been in decline for years, but scored a rare win yesterday after the White House halted plans that "would have curtailed rebates that drug manufacturers pay pharmacy benefit managers (PBMs) in return for winning placement of high-priced products on lists of drugs that insurers cover with affordable co-pays."Although CVS stock closed up 4.68% on the session, it was mostly a sell-the-news reaction. It was up as much as 8.6% before sellers swarmed and capitalized on the gift. The chart still looks terrible, but Thursday's jump did complete a five-month basing pattern, so there is a chance that a short-term bottom has been put in place.On the options trading front, optimism drove traders into call options throughout the session. By day's end, activity grew to 539% of the average daily volume, with 170,938 total contracts traded. Calls claimed 66% of the session's sum.Implied volatility jumped to 31% or the 41st percentile of its one-year range. Premiums are now pricing in daily moves of $1.13 or 1.9%. Merck (MRK)CVS Health wasn't the only stock impacted by the White House announcement. Companies that manufacture and sell drugs like Merck were whacked after the news. Barrons has an insightful take you can find here. * 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond The single day 4.5% drop took some $7 billion off the market cap of MRK stock and pushed it back below its 50-day moving average. The uptrend is now on shaky footing, and the stock is in technical no man's land. If the weakness persists, use $77 as your first downside target. It would take a recovery to $85 before negating the bearish signals created by Thursday's swoon.On the options trading front, put popularity only slightly edged out calls. By the closing bell, activity climbed to 392% of the average daily volume, with 100,295 total contracts traded. Puts accounted for 52% of the take.The plunge did light a fire under implied volatility, driving the measure up to 24% or the 52nd percentile of its one-year range. Premiums are officially pumped, suggesting short options strategies are the way to go if you're inclined to trade here.As of this writing, Tyler Craig didn't hold a position in any of the aforementioned securities. Check out his recently released Bear Market Survival Guide to learn how to defend your portfolio against market volatility. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Buy for Less Than Book * 7 Marijuana Stocks With Critical Levels to Watch * The 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond The post Friday's Vital Data: Bed Bath & Beyond, CVS and Merck appeared first on InvestorPlace.
This CBJ awards program recognizes financial leaders across the region who have set their companies up for success.
Despite deciding to "semi-retire" following her tenure as CFO at Family Dollar, Mary Winston's work in consulting and corporate board governance landed her at the helm of a Fortune 500 retailer.
Jim Cramer weighs in on Bed Bath & Beyond's quarter and what he expects from day two of Federal Reserve Chairman Jay Powell's testimony in front of the House Financial Committee.
In his second day of testimony, Fed Chair Jay Powell essentially confirmed that a rate cut is coming this month. For the market's part, the Fed Funds futures are pricing in at least a 25 basis point cut this month. To be fair, the market was already pricing in such a cut before Powell's comments, but even so, the market was again unable to hold onto a bulk of its opening gains. Let's look at a few top stock trades for Friday. Top Stock Trades for Tomorrow 1: Canopy Growth Click to EnlargeShares of Canopy Growth (NYSE:CGC) are taking a tumble on Thursday, down almost 5% so far on the day. However, the breakdown could be more than just a shakeout.InvestorPlace - Stock Market News, Stock Advice & Trading TipsCGC stock is cracking through a floor of support, showing that the descending triangle -- a bearish setup -- is in full force. If Canopy Growth can reclaim the $38-ish area and rally over $40, CGC could repair some of the technical damage. * 10 Stocks to Sell for an Economic Slowdown Below $38 and the setup remains bearish. Top Stock Trades for Tomorrow 2: Micron Click to EnlargeA few months ago we highlighted a potential breakout in Micron (NASDAQ:MU) with an ascending triangle -- the opposite setup of CGC. However, when uptrend support (blue line) gave way, the setup failed.Now, MU stock is back up into prior resistance near $44. Given the big run we've seen, I am going to assume $44 is resistance unless Micron stock can push through. On a retreat, let's see if $41 holds as support. If not, a retest of $39 could be on the table. Top Stock Trades for Tomorrow 3: Bed Bath & Beyond Click to EnlargeMan, Bed Bath & Beyond (NYSE:BBBY) has been a total disaster over the past few years. Shares have cratered 80% over the last five years, with Thursday's 3% fall not doing much to help.On the plus side though, BBBY stock has rallied strong off the lows at $10.43.At this point, we need to see the lows from December hold, at $10.21. Below and more selling can take place. On a rally, let's see if BBBY can reclaim the $12.50 level and the 10-week moving average. Top Stock Trades for Tomorrow 4: Cigna Click to EnlargeShares of Cigna (NYSE:CI) are ripping higher by more than 8% on Thursday. That's great news for bulls, although a stronger close would have been nice.CI stock ripped over the 200-week moving average, but was rejected by the 50-week moving average at $183.56. Furthermore, the 200-day moving average stood strong as resistance at $182.40.Further, the key $180 level couldn't be reclaimed either.So what now? * 3 Forgotten Tech Stocks Worth Remembering I want to see the $165 level and 200-week moving average act as support. If CI can maintain some of its newfound bullish momentum, I want to see how it handles the $180 level on the upside, as well as the 50-week moving average and 200-day moving average. Above could pave the way to $200. Otherwise, it could act as resistance.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Sell for an Economic Slowdown * 7 Marijuana Penny Stocks That I May Buy * 7 of The Best Schwab ETFs for Low Fees The post 4 Top Stock Trades for Friday: CGC, MU, BBBY appeared first on InvestorPlace.
The clock is ticking on Bed Bath & Beyond . While I think that the company can potentially be in better hands and the interim CEO Mary Winston did a serviceable job considering she's only been at the helm since the end of May, I think that she and the board have their work cut out for them -- and while they have slightly less than $1 billion in cash, I am beginning to wonder if they will need a chunk of that to stay relevant and more importantly to stave off competition. Given that former CEO Steve Tamares has been trying to constantly update and enhance their store experience, I have to wonder if anything can work in time to beat off a chain that almost seems to be targeting Bed Bath, and that's Target , which has multiple store formats that seem almost to be exactly like Bed Bath but with better selection and cheaper prices.